Please note…

You are now on the ey.com Switzerland site. To return to the ey.com United States site or other country site, click on the Switzerland (English) link on the upper right of this page, and select your preferred country site.

x
Skip to main navigation

News Releases 2012 - Ernst & Young - Switzerland

  • Share

News Releases 2012

02 May 2012
Impressive start of Swiss M&A in 2012, despite global challenges
The Swiss M&A market recorded an exceptional first quarter in 2012 as disclosed deal volume reached almost CHF 71b, representing total disclosed deal volume of the previous three quarters combined. This significant rise in deal volume compared to the previous quarters is mainly attributable to the announced merger between Glencore International and Xstrata. If completed, the CHF 49b transaction would rank among the largest Swiss deals in recent years.  

03 April 2012
Swiss Biotech Industry: high level of performance despite currency effects
2011 was a surprisingly good year for the Swiss biotech industry, despite negative currency effects and the continuing economic weakness which affected all export-driven industries. The signs are nevertheless positive. For example, the volume of investment in private and listed Swiss biotech companies increased sharply compared with the previous year.   

29 March 2012
Swiss and European governments to ensure that R&D is converted into new businesses, new products and additional jobs
National governments in Europe need to do more to ensure that R&D innovation in the biotech industry is translated into new businesses, new products and additional jobs according to a new report launched by Ernst & Young and EuropaBio, “What Europe has to offer biotechnology companies: unraveling the tax, financial and regulatory framework”.   

16 January 2012
Swiss M&A activity showed strong Q4 and full year 2011 performance
The Swiss M&A market showed a strong fourth quarter in 2011 in terms of number of transactions as well as disclosed deal volume, which grew by over 150% compared to the previous quarter. Jürg Stucker, Head of M&A at Ernst & Young Switzerland, explains: “With 216 announced M&A transactions, the number of deals in the fourth quarter remained close to the level of the first three quarters. 

10 January 2012
Survey: Declining optimism at Swiss banks
Of the 120 banks surveyed in December 2011 for the Ernst & Young Bank Barometer 2012 (not including the two major banks), just 15% (prior year: 52%) consider their current business development to be positive. 62% (40%) report a somewhat positive trend, while just under a quarter admit that business is developing negatively. Private and foreign banks were less confident in their assessment of business development, with around 40% complaining of a deterioration.

Bild Mitarbeiter am diskutieren

News

Contacts

Simone Isermann   
+41 58 286 35 97

Nadine Geissbühler     
+41 58 286 43 20

Nadine Greber    
+41 58 286 36 18

Fabienne Scholz-Kaiser 
+41 58 286 34 10

Back to top